Adachi Masayuki, Brenner David A
Department of Medicine, Columbia University College of Physicians and Surgeons, New York, NY 10032, USA.
Dig Dis. 2005;23(3-4):255-63. doi: 10.1159/000090173.
Alcoholic liver disease continues to be a major health problem with respect to both morbidity and mortality. To understand the clinical syndromes of alcoholic liver disease, this review highlights the papers on both clinical and basic research of alcoholic liver disease, especially on steatosis, alcoholic hepatitis and fibrosis.
The various forms of alcoholic liver disease are described, and knowledge about the clinical and pathophysiological features of different stages of alcoholic liver disease are summarized.
Clinical studies combined with basic research have established a spectrum of alcoholic liver disease from steatosis to steatohepatitis, fibrosis, and cirrhosis. New insights into the pathogenesis of alcoholic liver disease include the key roles of the excess production of cytokines, reactive oxygen species, and the shortage of protective mediators, including adiponectin.
These new insights will lead to new specific therapies for the treatment of alcoholic hepatitis and alcoholic liver fibrosis.
酒精性肝病在发病率和死亡率方面仍然是一个主要的健康问题。为了解酒精性肝病的临床综合征,本综述重点介绍了关于酒精性肝病临床和基础研究的论文,特别是关于脂肪变性、酒精性肝炎和纤维化的研究。
描述了酒精性肝病的各种形式,并总结了关于酒精性肝病不同阶段临床和病理生理特征的知识。
临床研究与基础研究相结合,确立了从脂肪变性到脂肪性肝炎、纤维化和肝硬化的一系列酒精性肝病。对酒精性肝病发病机制的新见解包括细胞因子过度产生、活性氧以及保护性介质(包括脂联素)缺乏的关键作用。
这些新见解将带来治疗酒精性肝炎和酒精性肝纤维化的新的特异性疗法。